T-cell acute lymphoblastic leukemia (ALL) is a rare disease in adults with inferior survival
outcomes compared with those seen in pediatric patients. Although potentially curable …

The role of hematopoietic cell transplantation (HCT) in adults with acute lymphoblastic
leukemia (ALL) is reviewed and critically evaluated in this systematic evidence-based …

Background CNS relapse of acute lymphocytic leukaemia is difficult to treat. Durable
remissions of relapsed or refractory B-cell acute lymphocytic leukaemia have been observed …

The introduction of agents targeted at specific molecular events is changing the treatment
paradigms in a number of malignancies. Historically, we have relied entirely on DNA …

The central nervous system (CNS) is the most important site of extramedullary disease in
adults with acute lymphoblastic leukemia (ALL). Although CNS disease is identified only in a …

The central nervous system (CNS) is an important site of involvement by acute lymphoblastic
leukemia (ALL) in adults. The prevalence is sufficiently high that prophylactic treatment is …

Allogeneic stem cell transplantation (SCT) is curative treatment in patients with acute
leukemia and myelodysplastic syndrome. However, recurrent disease is the major cause of …

Opinion statement Improvements in systemic therapy in the treatment of acute lymphoblastic
leukemia (ALL) and acute myeloid leukemia (AML) have improved patient outcomes and …

Anti‐cancer peptides (ACPs) represent a promising potential for cancer treatment, although
their mechanisms need to be further elucidated to improve their application in cancer …

Radiation in Central Nervous System Leukemia: Guidelines From the International Lymphoma
Radiation Oncology Group - International Journal of Radiation Oncology, Biology, Physics …